Mass Medical Angels is dedicated to providing funding and mentoring services the companies in the healthcare and life sciences sector.
Business Model:
Revenue: $0
Employees: 0-0
Address: -
City: Boston
State: MA
Zip: -
Country: US
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the life science community to achieve superior returns for their group, and more clinical innovation for the community.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
2/2014 | Sialix Cancer Research | Series B | 1.2M |
8/2011 | Lantos Technologies | Venture Round | 4.1M |
9/2010 | Lantos Technologies | Venture Round | 1.6M |
4/2014 | InfoBionic | Series B | 0 |
5/2011 | MoMelan Technologies | Series A | - |
2/2012 | Avaxia Biologics | Series A | 0 |
12/2020 | Coviu | Venture Round | 0 |
2/2014 | Siamab Therapeutics | Series B | 0 |
6/2013 | Avaxia Biologics | Series B | 0 |
12/2012 | Avaxia Biologics | Series B | 0 |
9/2010 | Polytouch Medical | Seed Round | 830k |
10/2009 | Daktari Diagnostics | Series A | 2.8M |
4/2014 | Sentieon | Series A | 0 |
6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
12/2009 | lifeIMAGE | Series A | 2.2M |
12/2011 | lifeIMAGE | Series B | 8.1M |
8/2018 | Capillary Biomedical | Seed Round | 0 |
7/2013 | Siamab Therapeutics | Series B | 2.5M |
6/2009 | lifeIMAGE | Series A | 2.7M |
6/2012 | Diffinity Genomics | Series B | - |
3/2018 | Lantos Technologies | Venture Round | 0 |
4/2017 | Sentien Biotechnologies | Series A | 12M |
2/2011 | Bliss Health | Seed Round | 500k |
5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
12/2020 | Coviu | Venture Round | 0 |
8/2018 | Capillary Biomedical | Seed Round | 0 |
6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
3/2018 | Lantos Technologies | Venture Round | 0 |
4/2017 | Sentien Biotechnologies | Series A | 0 |
4/2014 | InfoBionic | Series B | 0 |
4/2014 | Sentieon | Series A | 0 |
2/2014 | Sialix Cancer Research | Series B | 0 |
2/2014 | Siamab Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|